QuickView for methyltrienolone (compound)

1. GSE34589_SE_R_LNCaP cells with ELK1 shRNA knockdown treated with R1881
2. Prostate cancer LNCaP cells expressing PSF (SFPQ) or CTBP1-AS siRNA and treated with R-1881
3. Androgen receptor positive prostate cancer cell lines treated with R1881
4. Prostate cancer cell lines - manipulation of GABPA expression levels
5. Prostate carcinoma PC-3 cells expressing SUMOylation defective AR treated with R1881

1. The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid…
2. In vitro study of Organization for Economic Co-operation and Development (OECD) endocrine disruptor …
3. Androgen receptor agonism promotes an osteogenic gene program in preadipocytes.
4. Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and w…
5. PSA regulates androgen receptor expression in prostate cancer cells.

There were no clinical trials for methyltrienolone